Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, Par Value $0.0001 Per Share
-
Shares outstanding
-
23,267,064
-
Total 13F shares
-
23,552,943
-
Share change
-
-126,176
-
Total reported value
-
$7,127,866,991
-
Put/Call ratio
-
63%
-
Price per share
-
$302.64
-
Number of holders
-
303
-
Value change
-
-$58,976,544
-
Number of buys
-
142
-
Number of sells
-
161
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) as of Q2 2025
As of 30 Jun 2025,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) was held by
303 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,552,943 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, PAULSON & CO. INC., RTW INVESTMENTS, LP, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Avoro Capital Advisors LLC, BlackRock, Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, and UBS Group AG.
This page lists
305
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.